Ignite Creation Date:
2024-05-06 @ 5:45 PM
Last Modification Date:
2024-10-26 @ 2:34 PM
Study NCT ID:
NCT05411133
Status:
RECRUITING
Last Update Posted:
2024-01-23
First Post:
2022-05-25
Brief Title:
Treatment of Cabotamig ARB202 in Advanced Gastrointestinal Cancer Patients
Sponsor:
Arbele Pty Ltd
Organization:
Arbele Limited
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-05-30
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-08
Completion Date Type:
ESTIMATED
First Submit Date:
2022-05-25
First Submit QC Date:
June 5 2022
Study First Post Date:
2022-06-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-22
Last Update Post Date:
2024-01-23
Last Update Post Date Type:
ACTUAL